To start page
2012-5-19 +/-% Buy Sell Latest Volume Turnover (SEK)
NVP -3.42% 10.80 11.30 11.30 20 882 229 958.65
  • Home
  • About NeuroVive
  • Research & Development
  • Investors
  • Contact
Investors
  • Contacts
  • News releases
  • In the News
  • Stock
  • Shareholder reports
  • Corporate governance
  • Analyst coverage
  • Presentations
  • Ownership
  • Calendar
  • Financial calendar
Start / Investors / Shareholder reports / more...

Shareholder reports

2008 svensk flagga

Annual Report
Year-End Report
 Prospectus
Information leaflet

2007 svensk flagga

Annual Report

2006 svensk flagga

Annual Report

2005 svensk flagga

Annual Report

back to recent reports...

Eleonor Åsander Frostner

Responsible editor Eleonor Åsander Frostner eleonor.asander@neurovive.com Last updated: 2011-11-04

  • About NeuroVive
    • In brief
    • Board of Directors
    • Management Team
    • Advisory Board
    • Corporate Governance
    • Partnerships
    • Career
  • Research & Development
    • Project overview
    • Research overview
    • Our products
    • Relevant publications
  • Investors
    • Contacts
    • News releases
    • In the News
    • Stock
    • Shareholder reports
    • Corporate governance
    • Analyst coverage
    • Presentations
    • Ownership
    • Calendar
    • Financial calendar
  • Contact
    • Investors
    • Business development
    • Research

NeuroVive Pharmaceutical AB (publ), Biomedical Center, BMC D10, SE-221 84 Lund, Sweden

Tel: +46 (0)46 288 01 10 | Fax: +46 (0)46 888 83 48 | info@neurovive.com | Legal & Privacy